Amyloidosis and lung cancer.
Clinical systemic amyloidosis has been rarely described in patients with lung cancer. A new case of such an association is described with a review of the literature and a discussion about the possible biological mechanisms responsible for the development of systemic amyloidosis in patients with lung cancer. Circulating precursors of amyloid fibrils in patients with lung cancer might be implicated more than expected in the biology of tumoral disease.
Barceló
J Ramón
JR
Servicio de Oncología Médica, Hospital de Cruces, Bizkaia, Spain. jrbarcelo@hcru.osakidetza.net
Muñoz
Alberto
A
Mañé
Joan M
JM
Rubio
Itziar
I
Pérez-Hoyos
Teresa
T
Viteri
Ainhoa
A
López-Vivanco
Guillermo M
GM